Cargando…
Prognostic Significance of ESR1 Amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 Polymorphisms in Breast Cancer Patients
INTRODUCTION: Amplification of the ESR1 gene, coding for estrogen receptor alpha, was shown to predict responsiveness to tamoxifen, however its prognostic impact in breast cancer patients has not been thoroughly investigated. Other factors that could contribute to responsiveness to tamoxifen treatme...
Autores principales: | Markiewicz, Aleksandra, Wełnicka-Jaśkiewicz, Marzena, Skokowski, Jarosław, Jaśkiewicz, Janusz, Szade, Jolanta, Jassem, Jacek, Żaczek, Anna J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738574/ https://www.ncbi.nlm.nih.gov/pubmed/23951298 http://dx.doi.org/10.1371/journal.pone.0072219 |
Ejemplares similares
-
Clinical and Biological Significance of ESR1 Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients
por: Nagel, Anna, et al.
Publicado: (2019) -
Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
por: Markiewicz, Aleksandra, et al.
Publicado: (2012) -
Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential
por: Markiewicz, Aleksandra, et al.
Publicado: (2014) -
Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer
por: Markiewicz, Aleksandra, et al.
Publicado: (2013) -
Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2018)